Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 2, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 3, 2026
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-001156
Filed / recorded
Feb 3, 2026, 9:12 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BOSTON SCIENTIFIC CORP
Issuer CIK
885725
Ticker
BSX
Reporting person
Michael F Mahoney
Relationship
Director, Officer
Officer title
Chairman, President & CEO
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Feb 2, 2026
Transaction code
M
Shares / units
49,407
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
98,814
Ownership form
Direct
Amendment
No
Footnotes from the filing
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.